Skip to content
sellWeak

Barbara Ryan sold $19k of INKT

director at MiNK Therapeutics, Inc.. 1,500 shares at an average of $12.76, traded Jun 4, 2026, filed Jun 5, 2026.

Warning score
15
Value
$19k
1,500 shares
Holdings after
21,969
-6% from before
From 52-week low
+83%
low $6.98, close $12.75
From 52-week high
-80%
high $64.17, as of Jun 4, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $19k at market
    0
  • Share of holdings sold
    Sold 6.4% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

INKTOct 9, 2026 · close 10.72
Since filing Jun 5, 2026: -9.7%SPY +6.0% · excess -15.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-260084, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 4, 2026SOpen-market sale
Common Stock
-500$12.68$6,34222,969Jun 5, 2026
Jun 4, 2026SOpen-market sale
Common Stock
-1,000$12.80$13k21,969Jun 5, 2026

Related signals

Other insiders at MiNK Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
15Weak
INKTsell
MiNK Therapeutics, Inc.
Barbara Ryan
director
$22k
1,500 shares
-7%
15Weak
INKTsell
MiNK Therapeutics, Inc.
Barbara Ryan
director
$5,426
500 shares
-2%
15Weak
INKTbuy
MiNK Therapeutics, Inc.
Agenus Inc
owner
$25k
22,975 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Barbara Ryan sold $19k of INKT | InsiderTell